Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

Go back to Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.62 --0 (-0%)
Previous Close $0.62    52 Week High
Open $0.62    52 Week Low
Day High $0.62    P/E N/A 
Day Low $0.62    EPS
Volume 12,293